Urinary excretion of platelet-activating factor in human and experimental nephrosis

Nephrology Dialysis Transplantation

Volumn 11, Issue 2, 1996, Pages 282-286

  Bustos, C ^a   Gonzalez E ^a   Gonzalez Cuadrado S ^a   Ortiz, A ^a   Muley, R ^b   De Nicolas R ^a   Plaza, J J ^a   Egido, J ^a,c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c Renal Unit   (Spain)

Author keywords

Nephrosis; Platelet activating factor; Urine

Indexed keywords

PUROMYCIN AMINONUCLEOSIDE; THROMBOCYTE ACTIVATING FACTOR;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GLOMERULUS FILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NEPHROSIS; NEPHROTIC SYNDROME; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; RAT; SCHOOL CHILD; THIN LAYER CHROMATOGRAPHY; URINARY EXCRETION;

EID: 0030025865     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027254     Document Type: Article

References (23)

1. Chao W, Olson MS. Platelet-activating factor: receptors and signal transduction. Biochem J 1993; 292: 617-629
2. 2 synthesis, arachidonic acid release and contraction of cultured rat mesangial cells. J Clin Invest 1984; 73: 1227-1231
3. Camussi G, Tetta C, Coda R et al. Platelet-activating factor induced loss of glomerular anionic charges. Kidney Int 1984; 25: 73-81
4. Ortiz A, Gómez-Chiarri M, Lerma JL, Gonzâlez E, Egido J. The role of platelet-activating factor in experimental glomerular injury. Lipids 1991; 26: 1310-1315
5. Gómez-Chiarri M, Ortiz A, Lerma JL et al. Involvement of tumor necrosis factor and platelet activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest 1994; 70: 449-460
6. Baldi E, Emancipator SN, Hassan MO et al. Platelet-activating factor receptor blockade ameliorates murine systemic lupus erithematosus. Kidney Int 1990; 38: 1030-1038
7. Egido J, Robles A, Ortiz A et al. Role of platelet-activating factor in adriamycin-induced nephropathy in rats. Eur J Pharmacol 1987; 138: 119-123
8. Bustos C, González E, Muley R et al. Increase of tumor necrosis factor synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 1994; 24: 799-805
9. Sánchez-Crespo M, Iñarrea P, Alvarez V et al. Presence in normal urine of a hypotensive and platelet activating phospholipid. Am J Physiol 1983; 244: F706-F711
10. Noris M, Perico N, Macconi D et al. Renal metabolism and urinary excretion of platelet-activating factor in the rat. J Biol Chem 1990; 265: 19414-19419
11. Pinckard RN, Farr RS, Hanahan DJ. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE-sensitized basophils. J Immunol 1987; 123: 1847-1857
12. Satouchi K, Pinkard RN, McManus LM, Hanahan DJ. Modification of the polar head group of acetylglycerylether phosphorylcholine and subsequent effect upon platelet activation. J Biol Chem 1981; 256: 4225-4232
13. Henson PM. Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response. J Exp Med 1976; 143: 937-952
14. Kreisberg JI, Hoover RL, Karnovsky MJ. Isolation and characterization of rat glomerular epithelial cells in vitro. Kidney Int 1978; 14: 21-30
15. 4 metabolism. J Immunol 1987; 138: 3918-3926
16. Blank ML, Snyder F. Improved high-performance liquid ChromatographiC method for isolation of platelet activating factor from other phospholipids. J Chomatogr 1983; 273: 415-420
17. Morigi M, Macconi D, Riccardi E et al. Platelet activating factor receptor blocking reduces proteinuria and improves survival in lupus autoimmune mice. J Pharmacol Exp Ther 1991; 258: 601-606
18. Lianos EA, Zanglis A. Glomerular platelet-activating factor levels and origin in experimental glomerulonephritis. Kidney Int 1990; 37: 736-740
19. Demopoulos CA, Andrikopoulos NK, Antonopoulos S. A simple and precise method for the routine determination of platelet activating factor in blood and urine. Lipids 1994; 29: 305-309
20. Noris M, Benigni A, Boccardo P et al. Urinary excretion of platelet activating factor in patients with immune-mediated glomerulonephritis. Kidney Int 1993; 43: 426-429
21. Bustos C, Gónzalez-Cuadrado S, Ruiz-Ortega M et al. Cyclosporin A (CsA) modulates the glomerular production of inflammatory mediators and proteoglycans in experimental nephrosis. Clin Exp Immunol 1995; (December)
22. Sedor JR. Abboud HE. Platelet-activating factor stimulates oxygen radical release by cultured mesangial cells. Kidney Int 1985; 27: 222A
23. Kashihara N, Watanabe Y, Makino H, Wallner EI, Kanwar YS. Selective decreased de novo synthesis of glomerular proteoglycans under the influence of reactive oxygen species. Proc Natl Acad Sci USA 1992; 89: 6309-6313